FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/25/2025
Back to search
Official data from USPTO
LNCTAC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
12/26/2025
Trademark type
Combined
Nice classes
5, 42
Filing date
03/08/2024
Registration date
05/06/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/06/2025
Last transaction
12/26/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
CN
Examiner
BROWN,TINA
Law office
M90
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the wording "LNCTAC" in stylized font.
Holders and representatives
Holders
Chengdu Lnctac Biotechnology Co., Ltd.
Representatives
Justin Brown Brown Brothers Law LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for human purposes for treatment of oncological diseasesdermatological disordersrespiratory diseasescardiovascular diseasesneurodegenerative disorders; reagents for medical purposes; pharmaceutical preparations for the treatment of cancerskin infectionschronic respiratory conditionscardiovascular diseasesneurodegenerative conditions; diagnostic preparations for medical purposes; medicines for veterinary purposes for treatment of infectious diseasesmetabolic disordersinflammatory conditions in animals; nutraceutical preparations for therapeutic and medical purposes for the treatment of immune deficienciesmetabolic disordersinflammatory conditions; dietetic substances adapted for medical usedietetic foods and beverages adapted for medical usedietetic preparations adapted for medical purposes; disinfectants; medical dressings; vaccines
Class 42
Technological research in the field of computer hardware systems and renewable energy resources; research and analysis of biochemistry; medical research laboratory services; genetic testing for scientific research purposes; medical research; biological research and analysis; stem cell research services; development of pharmaceutical preparations and medicines; scientific research in the nature of conducting clinical trials for others; industrial design
Publications
History of USPTO decisions and trademark events.
29 publications found
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/18/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/04/2025
FIMP
FINAL DISPOSITION PROCESSED
12/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/03/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/03/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/06/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/06/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
05/06/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/18/2025
PUBO
PUBLISHED FOR OPPOSITION
03/18/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/24/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
02/24/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/24/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
02/24/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/24/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/20/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/20/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/20/2025
RFNT
REFUSAL PROCESSED BY IB
10/12/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/25/2024
RFRR
REFUSAL PROCESSED BY MPU
09/25/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/22/2024
CNRT
NON-FINAL ACTION WRITTEN
09/21/2024
DOCK
ASSIGNED TO EXAMINER
09/20/2024
MAFR
APPLICATION FILING RECEIPT MAILED
07/10/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/10/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/04/2024
Continuous trademark protection
Get notified about every new filing that threatens LNCTAC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.